Reaction Details Report a problem with these data
Target
Mu-type opioid receptor
Ligand
BDBM438902
Substrate
n/a
Meas. Tech.
Competitive Displacement Assay
Ki
<1±n/a nM
Citation
 Wynn, TA; Alvarez, JC; Moustakas, DT; Haeberlein, M; Pennington, LD Compounds for the treatment of pain US Patent  US10604489 Publication Date 3/31/2020 
Target
Name:
Mu-type opioid receptor
Synonyms:
M-OR-1 | MOP | MOR-1 | MOR1 | MUOR1 | Mu Opioid Receptor | Mu opiate receptor | OPIATE Mu | OPRM1 | OPRM_HUMAN | hMOP | mu-type opioid receptor isoform MOR-1
Type:
G Protein-Coupled Receptor (GPCR)
Mol. Mass.:
44789.51
Organism:
Homo sapiens (Human)
Description:
P35372
Residue:
400
Sequence:
MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP
  
Inhibitor
Name:
BDBM438902
Synonyms:
3-((1R,5S,9r)-9-methoxy-3-(2-(2-oxoimidazolidin-1-yl)ethyl)-3-azabicyclo[3.3.1]nonan-9-yl)benzamide hydrochloride | US10604489, Compound 63 | US11180455, Compound 63
Type:
Small organic molecule
Emp. Form.:
C21H30N4O3
Mol. Mass.:
386.4879
SMILES:
COC1(C2CCCC1CN(CCN1CCNC1=O)C2)c1cccc(c1)C(N)=O |TLB:10:9:2:5.4.6,19:2:5.4.6:8.18.9,THB:1:2:5.4.6:8.18.9|
Structure:
Search PDB for entries with ligand similarity: